Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: Safety and survival. Issue 1 (February 2018) - Invernizzi, F.; Iavarone, M.; Donato, M.F.; Sangiovanni, A.; Monico, S.; Manini, M.A.; Maggi, U.; Antonelli, B.; Dondossola, D.; Rossi, G.; Lampertico, P.